1. Home
  2. ATRA
  3. ATRA News

Latest Atara Biotherapeutics Inc. (ATRA) News on July 27, 2024

US FDA grants priority review for Pierre Fabre’s EBV+ PTLD
ATRA

Pharmaceutical Technology

8 days ago

US FDA grants priority review for Pierre Fabre’s EBV+ PTLD

FDA priority review advances Atara’s tabelecleucel for viral infection
ATRA

Pharmaceutical Technology

9 days ago

FDA priority review advances Atara’s tabelecleucel for viral infection

ATRA

MT Newswires

9 days ago

Atara Biotherapeutics Says Tab-Cel Biologics License Application Gets FDA Priority Review

Atara Biotherapeutics Announces U.S. FDA Acceptance and Priority Review of the Biologics License Application for Tabelecleucel (Tab-cel®) for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease
ATRA

Business Wire

9 days ago

Atara Biotherapeutics Announces U.S. FDA Acceptance and Priority Review of the Biologics License Application for Tabelecleucel (Tab-cel®) for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease

Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now
ATRA

GlobeNewswire

10 days ago

Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now

All You Need to Know About Atara Biotherapeutics (ATRA) Rating Upgrade to Strong Buy
ATRA

Zacks

11 days ago

All You Need to Know About Atara Biotherapeutics (ATRA) Rating Upgrade to Strong Buy

Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
ATRA

Business Wire

21 days ago

Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Atara Biotherapeutics To Participate at the Stifel Virtual Cell Therapy Forum
ATRA

Business Wire

23 days ago

Atara Biotherapeutics To Participate at the Stifel Virtual Cell Therapy Forum

Atara Biotherapeutics’ Ebvallo™ (tabelecleucel) Wins Prix Galien International Award for Best Product for Orphan/Rare Diseases
ATRA

Business Wire

a month ago

Atara Biotherapeutics’ Ebvallo™ (tabelecleucel) Wins Prix Galien International Award for Best Product for Orphan/Rare Diseases

Atara Biotherapeutics Announces 1-for-25 Reverse Stock Split
ATRA

Business Wire

a month ago

Atara Biotherapeutics Announces 1-for-25 Reverse Stock Split

Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now
ATRA

GlobeNewswire

a month ago

Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now

Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
ATRA

Business Wire

2 months ago

Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Atara Biotherapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
ATRA

Business Wire

2 months ago

Atara Biotherapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Atara Biotherapeutics Presents Preclinical Data on ATA3219, an Allogeneic CD19-Targeted CAR T Therapy for the Treatment of B-Cell Driven Autoimmune Diseases, at the ISCT 2024 Annual Meeting
ATRA

Business Wire

2 months ago

Atara Biotherapeutics Presents Preclinical Data on ATA3219, an Allogeneic CD19-Targeted CAR T Therapy for the Treatment of B-Cell Driven Autoimmune Diseases, at the ISCT 2024 Annual Meeting

Biogen (BIIB) to Buy HI-Bio to Expand Rare Disease Pipeline
ATRA

Zacks

2 months ago

Biogen (BIIB) to Buy HI-Bio to Expand Rare Disease Pipeline

GSK Studies on Depemokimab for Severe Asthma Meet Primary Goals
ATRA

Zacks

2 months ago

GSK Studies on Depemokimab for Severe Asthma Meet Primary Goals

ATRA

MT Newswires

2 months ago

Atara Biotherapeutics Files Biologics License Application for Tabelecleucel with FDA; Shares Rise

Atara Biotherapeutics Submits Tabelecleucel (Tab-cel®) Biologics License Application for Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease with U.S. FDA
ATRA

Business Wire

2 months ago

Atara Biotherapeutics Submits Tabelecleucel (Tab-cel®) Biologics License Application for Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease with U.S. FDA

Atara Biotherapeutics First Quarter 2024 Earnings: Beats Expectations
ATRA

Simply Wall St.

3 months ago

Atara Biotherapeutics First Quarter 2024 Earnings: Beats Expectations

Atara Biotherapeutics (ATRA) Reports Q1 Loss, Tops Revenue Estimates
ATRA

Zacks

3 months ago

Atara Biotherapeutics (ATRA) Reports Q1 Loss, Tops Revenue Estimates

ATRA

Associated Press Finance

3 months ago

Atara Biotherapeutics: Q1 Earnings Snapshot

Atara Biotherapeutics Announces First Quarter 2024 Financial Results and Operational Progress
ATRA

Business Wire

3 months ago

Atara Biotherapeutics Announces First Quarter 2024 Financial Results and Operational Progress

Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
ATRA

Business Wire

3 months ago

Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
ATRA

Business Wire

4 months ago

Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Atara Biotherapeutics (ATRA) Reports Q4 Loss, Tops Revenue Estimates
ATRA

Zacks

4 months ago

Atara Biotherapeutics (ATRA) Reports Q4 Loss, Tops Revenue Estimates

ATRA

Associated Press Finance

4 months ago

Atara Biotherapeutics: Q4 Earnings Snapshot

Atara Biotherapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Operational Progress
ATRA

Business Wire

4 months ago

Atara Biotherapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Operational Progress

Atara Biotherapeutics Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219, an Allogeneic CAR T Therapy
ATRA

Business Wire

5 months ago

Atara Biotherapeutics Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219, an Allogeneic CAR T Therapy

Atara Biotherapeutics to Participate in Cell Therapy Panel Discussion at the Cowen 44th Annual Health Care Conference
ATRA

Business Wire

5 months ago

Atara Biotherapeutics to Participate in Cell Therapy Panel Discussion at the Cowen 44th Annual Health Care Conference

Atara Biotherapeutics Announces Submission of Investigational New Drug Application for ATA3219 for Treatment of Lupus Nephritis
ATRA

Business Wire

5 months ago

Atara Biotherapeutics Announces Submission of Investigational New Drug Application for ATA3219 for Treatment of Lupus Nephritis

After losing 76% in the past year, Atara Biotherapeutics, Inc. (NASDAQ:ATRA) institutional owners must be relieved by the recent gain
ATRA

Simply Wall St.

6 months ago

After losing 76% in the past year, Atara Biotherapeutics, Inc. (NASDAQ:ATRA) institutional owners must be relieved by the recent gain

Atara Biotherapeutics and Pierre Fabre Laboratories Announce Publication of Phase 3 ALLELE Tab-cel® Data in The Lancet Oncology
ATRA

Business Wire

6 months ago

Atara Biotherapeutics and Pierre Fabre Laboratories Announce Publication of Phase 3 ALLELE Tab-cel® Data in The Lancet Oncology

Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results on February 7, 2024
ATRA

PR Newswire

6 months ago

Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results on February 7, 2024

Strength Seen in Avidity Biosciences, Inc. (RNA): Can Its 15.0% Jump Turn into More Strength?
ATRA

Zacks

6 months ago

Strength Seen in Avidity Biosciences, Inc. (RNA): Can Its 15.0% Jump Turn into More Strength?

Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference
ATRA

PR Newswire

6 months ago

Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference

HOOKIPA Pharma Provides Update on Business Priorities and Oncology Partnership Programs
ATRA

GlobeNewswire

6 months ago

HOOKIPA Pharma Provides Update on Business Priorities and Oncology Partnership Programs

ATRA

Business Wire

6 months ago

AMTD Digital’s Entertainment and Movie Businesses Are Estimated to Contribute Significantly to Net Profit

BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. Declares Monthly Distribution
ATRA

Business Wire

6 months ago

BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. Declares Monthly Distribution

ATRA

Business Wire

6 months ago

AMTD Digital’s Half Yearly Net Profit is Estimated to Increase over 150% Year over Year

Charles Schwab Boosts Its Online Brokerage With Big TD Ameritrade Deal
ATRA

Investor's Business Daily

6 months ago

Charles Schwab Boosts Its Online Brokerage With Big TD Ameritrade Deal

Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology
ATRA

PR Newswire

6 months ago

Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology

Canoo: Buy, Sell, or Hold?
ATRA

Motley Fool

6 months ago

Canoo: Buy, Sell, or Hold?

Schwab Earnings Beat Estimates. Why the Stock Is Dropping.
ATRA

Barrons.com

6 months ago

Schwab Earnings Beat Estimates. Why the Stock Is Dropping.

Canoo Delivered Electric Vehicles to Kingbee
ATRA

GlobeNewswire

6 months ago

Canoo Delivered Electric Vehicles to Kingbee

Loop Industries Reports Third Quarter Fiscal 2024 Results and Provides Updates on Business Developments
ATRA

ACCESSWIRE

6 months ago

Loop Industries Reports Third Quarter Fiscal 2024 Results and Provides Updates on Business Developments

Voya Global Advantage and Premium Opportunity Fund & Voya Infrastructure, Industrials and Materials Fund Announces Payment of Quarterly Distribution
ATRA

Business Wire

6 months ago

Voya Global Advantage and Premium Opportunity Fund & Voya Infrastructure, Industrials and Materials Fund Announces Payment of Quarterly Distribution

Lavoro to Announce Fiscal First Quarter 2024 Results on January 24th, 2024
ATRA

GlobeNewswire

6 months ago

Lavoro to Announce Fiscal First Quarter 2024 Results on January 24th, 2024

Sidoti Events, LLC's Virtual January Micro-Cap Conference
ATRA

ACCESSWIRE

6 months ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

Four New Produce Companies Join Expanding ReposiTrak Traceability Network to Share Traceability Data With Retailers, Wholesalers
ATRA

Business Wire

6 months ago

Four New Produce Companies Join Expanding ReposiTrak Traceability Network to Share Traceability Data With Retailers, Wholesalers

ARIS MINING ACHIEVES 2023 PRODUCTION GUIDANCE AND PROVIDES 2024 OUTLOOK
ATRA

PR Newswire

6 months ago

ARIS MINING ACHIEVES 2023 PRODUCTION GUIDANCE AND PROVIDES 2024 OUTLOOK

EV Roundup: TSLA's Berlin Output Halt & HMC's New EV Series Hog the Limelight
ATRA

Zacks

6 months ago

EV Roundup: TSLA's Berlin Output Halt & HMC's New EV Series Hog the Limelight

What Makes FinWise Bancorp (FINW) a Good Fit for 'Trend Investing'
ATRA

Zacks

6 months ago

What Makes FinWise Bancorp (FINW) a Good Fit for 'Trend Investing'

Vast Announces Appointment of Two Additional Directors to its Recently Expanded Board of Directors
ATRA

Business Wire

6 months ago

Vast Announces Appointment of Two Additional Directors to its Recently Expanded Board of Directors

Seth Klarman's Firm Exits Atara Biotherapeutics Inc Holding
ATRA

GuruFocus.com

7 months ago

Seth Klarman's Firm Exits Atara Biotherapeutics Inc Holding

Seth Klarman's Exit from Atara Biotherapeutics Inc
ATRA

GuruFocus.com

7 months ago

Seth Klarman's Exit from Atara Biotherapeutics Inc

Oncolytics Biotech® Appoints Patricia S. Andrews to its Board of Directors
ATRA

CNW Group

7 months ago

Oncolytics Biotech® Appoints Patricia S. Andrews to its Board of Directors

VirTra, Inc. (VTSI) Hits Fresh High: Is There Still Room to Run?
ATRA

Zacks

7 months ago

VirTra, Inc. (VTSI) Hits Fresh High: Is There Still Room to Run?

Atara Biotherapeutics Announces $15 Million Registered Direct Offering
ATRA

Business Wire

7 months ago

Atara Biotherapeutics Announces $15 Million Registered Direct Offering

Stoke Therapeutics Highlights Strategic Priorities and Anticipated Milestones for 2024
ATRA

Business Wire

7 months ago

Stoke Therapeutics Highlights Strategic Priorities and Anticipated Milestones for 2024

Atara Biotherapeutics to Present Recent Progress and Key Upcoming Milestones at the 42nd Annual J.P. Morgan Healthcare Conference
ATRA

Business Wire

7 months ago

Atara Biotherapeutics to Present Recent Progress and Key Upcoming Milestones at the 42nd Annual J.P. Morgan Healthcare Conference

Loss-Making Beam Global (NASDAQ:BEEM) Expected To Breakeven In The Medium-Term
ATRA

Simply Wall St.

7 months ago

Loss-Making Beam Global (NASDAQ:BEEM) Expected To Breakeven In The Medium-Term

AMTD IDEA Awarded "Best Financial Services" Recognition
ATRA

Business Wire

7 months ago

AMTD IDEA Awarded "Best Financial Services" Recognition

Stoke Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
ATRA

Business Wire

7 months ago

Stoke Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Atara Biotherapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
ATRA

Business Wire

7 months ago

Atara Biotherapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Black Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones
ATRA

GlobeNewswire

7 months ago

Black Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones

ZeroFox Awarded $289M from U.S. Office of Personnel Management for Digital Identity Protection Services
ATRA

GlobeNewswire

7 months ago

ZeroFox Awarded $289M from U.S. Office of Personnel Management for Digital Identity Protection Services

INOVIO and Coherus Announce Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI™ (toripalimab-tpzi)
ATRA

PR Newswire

7 months ago

INOVIO and Coherus Announce Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI™ (toripalimab-tpzi)

3 Communication Stocks Likely to Sail Against Industry Odds
ATRA

Zacks

7 months ago

3 Communication Stocks Likely to Sail Against Industry Odds

Theseus Pharmaceuticals Enters into Agreement to Be Acquired by Concentra Biosciences for between $3.90 and $4.05 in Cash per Share Plus a Contingent Value Right
ATRA

PR Newswire

7 months ago

Theseus Pharmaceuticals Enters into Agreement to Be Acquired by Concentra Biosciences for between $3.90 and $4.05 in Cash per Share Plus a Contingent Value Right

Estimating The Fair Value Of Niu Technologies (NASDAQ:NIU)
ATRA

Simply Wall St.

7 months ago

Estimating The Fair Value Of Niu Technologies (NASDAQ:NIU)

Atara Biotherapeutics Announces Closing of Expanded Global Tab-cel® Partnership with Pierre Fabre Laboratories
ATRA

Business Wire

7 months ago

Atara Biotherapeutics Announces Closing of Expanded Global Tab-cel® Partnership with Pierre Fabre Laboratories

Nature’s Sunshine Recognized with Best Company Culture Award
ATRA

GlobeNewswire

7 months ago

Nature’s Sunshine Recognized with Best Company Culture Award

Voya Global Advantage and Premium Opportunity Fund & Voya Infrastructure, Industrials and Materials Fund Declare Quarterly Distributions
ATRA

Business Wire

7 months ago

Voya Global Advantage and Premium Opportunity Fund & Voya Infrastructure, Industrials and Materials Fund Declare Quarterly Distributions

Loop Industries Announces Its Loop(TM) Branded PET Resin Is Compliant for Pharmaceutical Industry Packaging Applications
ATRA

ACCESSWIRE

7 months ago

Loop Industries Announces Its Loop(TM) Branded PET Resin Is Compliant for Pharmaceutical Industry Packaging Applications

Reviva to Participate in the Zacks Small-Cap Research Life Sciences Investor Forum
ATRA

GlobeNewswire

8 months ago

Reviva to Participate in the Zacks Small-Cap Research Life Sciences Investor Forum

New Strong Buy Stocks for December 11th
ATRA

Zacks

8 months ago

New Strong Buy Stocks for December 11th

Does The Market Have A Low Tolerance For DHI Group, Inc.'s (NYSE:DHX) Mixed Fundamentals?
ATRA

Simply Wall St.

8 months ago

Does The Market Have A Low Tolerance For DHI Group, Inc.'s (NYSE:DHX) Mixed Fundamentals?

Lanvin Group Announces New CEO
ATRA

PR Newswire

8 months ago

Lanvin Group Announces New CEO

Adverum Biotechnologies to Present LUNA Preliminary Efficacy and Safety Data at the 47th Annual Meeting of the Macula Society
ATRA

GlobeNewswire

8 months ago

Adverum Biotechnologies to Present LUNA Preliminary Efficacy and Safety Data at the 47th Annual Meeting of the Macula Society

Innovid to Present at Upcoming Investor Conferences
ATRA

PR Newswire

8 months ago

Innovid to Present at Upcoming Investor Conferences

Hyliion Holdings Corp. (NYSE: HYLN) to Host Tech Fireside Chat Showcasing KARNO Linear Generator Technology on December 12th
ATRA

Business Wire

8 months ago

Hyliion Holdings Corp. (NYSE: HYLN) to Host Tech Fireside Chat Showcasing KARNO Linear Generator Technology on December 12th

Optinose Announces 3-Month Extension of FDA Review Period for the Supplemental New Drug Application for XHANCE
ATRA

GlobeNewswire

8 months ago

Optinose Announces 3-Month Extension of FDA Review Period for the Supplemental New Drug Application for XHANCE

Sangoma Technologies Partnership Powers UK PSTN Switch-Off Opportunities
ATRA

Business Wire

8 months ago

Sangoma Technologies Partnership Powers UK PSTN Switch-Off Opportunities

Bogota Financial Corp. Announces CEO Transition
ATRA

Business Wire

8 months ago

Bogota Financial Corp. Announces CEO Transition

Risk and Reward: 3 Bank Stocks for the Bold Investor
ATRA

InvestorPlace

8 months ago

Risk and Reward: 3 Bank Stocks for the Bold Investor

Theseus (THRX) Up 57% in a Month on Strategic Restructuring Plan
ATRA

Zacks

8 months ago

Theseus (THRX) Up 57% in a Month on Strategic Restructuring Plan

Theseus Pharmaceuticals Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital, LLC and OrbiMed Advisors LLC and Unsolicited Proposal from Concentra Biosciences LLC
ATRA

PR Newswire

8 months ago

Theseus Pharmaceuticals Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital, LLC and OrbiMed Advisors LLC and Unsolicited Proposal from Concentra Biosciences LLC

Investors Don't See Light At End Of CPI Card Group Inc.'s (NASDAQ:PMTS) Tunnel
ATRA

Simply Wall St.

8 months ago

Investors Don't See Light At End Of CPI Card Group Inc.'s (NASDAQ:PMTS) Tunnel

3 Medical Services Stocks to Buy as Industry Trends Improve
ATRA

Zacks

8 months ago

3 Medical Services Stocks to Buy as Industry Trends Improve

Insider Buying: Taysha Gene Therapies Board Observer Bought US$163k Of Shares
ATRA

Simply Wall St.

8 months ago

Insider Buying: Taysha Gene Therapies Board Observer Bought US$163k Of Shares

Optinose to Present at the 35th Annual Piper Sandler Healthcare Conference
ATRA

GlobeNewswire

8 months ago

Optinose to Present at the 35th Annual Piper Sandler Healthcare Conference

Toro Corp. Announces the Completion of the Sale of the M/T Wonder Formosa
ATRA

GlobeNewswire

8 months ago

Toro Corp. Announces the Completion of the Sale of the M/T Wonder Formosa

The past three years for AXT (NASDAQ:AXTI) investors has not been profitable
ATRA

Simply Wall St.

8 months ago

The past three years for AXT (NASDAQ:AXTI) investors has not been profitable

ATRA

Thomson Reuters StreetEvents

8 months ago

Q3 2023 DiaMedica Therapeutics Inc Earnings Call

GLAZER CAPITAL, LLC Adjusts Position in Tristar Acquisition I Corp
ATRA

GuruFocus.com

8 months ago

GLAZER CAPITAL, LLC Adjusts Position in Tristar Acquisition I Corp

Atomera Achieves Revenue Milestone Under First Commercial License Agreement
ATRA

ACCESSWIRE

8 months ago

Atomera Achieves Revenue Milestone Under First Commercial License Agreement

DiaMedica Therapeutics Inc. (DMAC) Reports Third Quarter 2023 Financial Results
ATRA

GuruFocus.com

8 months ago

DiaMedica Therapeutics Inc. (DMAC) Reports Third Quarter 2023 Financial Results

Telesat Selects Aalyria’s Spacetime for Orchestration of Its Revolutionary Telesat Lightspeed Constellation
ATRA

GlobeNewswire

8 months ago

Telesat Selects Aalyria’s Spacetime for Orchestration of Its Revolutionary Telesat Lightspeed Constellation

ATRA

GlobeNewswire

8 months ago

Quadro Acquisition One Corp. Announces Correction in Contribution Amount in Connection with its Proposed Extension

Ventyx Biosciences to Participate in the Jefferies London Healthcare Conference
ATRA

GlobeNewswire

9 months ago

Ventyx Biosciences to Participate in the Jefferies London Healthcare Conference

Share on Social Networks: